What is Barrington Research’s Estimate for USPH Q3 Earnings?

U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities research analysts at Barrington Research raised their Q3 2025 earnings per share estimates for shares of U.S. Physical Therapy in a research report issued on Friday, February 28th. Barrington Research analyst M. Petusky now anticipates that the company will earn $0.67 per share for the quarter, up from their previous estimate of $0.62. Barrington Research currently has a “Outperform” rating and a $98.00 target price on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.67 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q3 2026 earnings at $0.79 EPS.

Several other equities analysts also recently issued reports on USPH. JPMorgan Chase & Co. upped their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Tuesday, December 3rd. William Blair restated a “market perform” rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. JMP Securities started coverage on U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. Finally, StockNews.com cut shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $111.50.

U.S. Physical Therapy Trading Down 0.2 %

Shares of U.S. Physical Therapy stock opened at $79.46 on Monday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a fifty day simple moving average of $87.99 and a 200-day simple moving average of $87.62. The stock has a market cap of $1.20 billion, a price-to-earnings ratio of 84.53, a PEG ratio of 3.54 and a beta of 1.48. U.S. Physical Therapy has a 12-month low of $76.18 and a 12-month high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million.

Hedge Funds Weigh In On U.S. Physical Therapy

Large investors have recently modified their holdings of the business. Point72 Asset Management L.P. acquired a new position in U.S. Physical Therapy during the fourth quarter worth $18,886,000. Bahl & Gaynor Inc. grew its stake in shares of U.S. Physical Therapy by 135.4% during the 4th quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company’s stock worth $23,076,000 after purchasing an additional 149,622 shares during the period. State Street Corp increased its holdings in shares of U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after purchasing an additional 99,244 shares in the last quarter. Copeland Capital Management LLC increased its holdings in shares of U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after purchasing an additional 72,715 shares in the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at about $6,240,000.

Insider Activity

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of U.S. Physical Therapy stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $96.25, for a total value of $49,665.00. Following the sale, the chief financial officer now owns 20,469 shares of the company’s stock, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be issued a $0.45 dividend. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.27%. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s payout ratio is presently 97.83%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.